Magnetic resonance imaging of breast lesions-a pathologic correlation
Male breast cancer: a review of clinical management
Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity
Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers
Characterization of molecular and structural determinants of selective estrogen receptor downregulators
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients
Physician and patient characteristics associated with outpatient breast cancer screening recommendations in the United States: analysis of the National Ambulatory Medical Care Survey Data 1996-2004
Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression
Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies
The effects of radiotherapy for the treatment of contralateral breast cancer
Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging
Association between reproductive factors and breast cancer survival in younger women
Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer
Is survivin expression nevertheless related to disease outcome in breast cancer?
CHEK2 1100delC is present in familial breast cancer cases of the Basque Country
29th Annual San Antonio Breast Cancer Symposium 2006
Dose-dense sequential chemotherapy with epirubicin (E), paclitaxel (T) and cyclophosphamide (C) (ETC) in comparison to conventional dosed chemotherapy in high-risk breast cancer patients (≥4 + LN). Mature results of an AGO-trial
20 year follow-up of the Royal Marsden tamoxifen breast cancer prevention trial
A randomized trial of CEF versus dose dense EC followed by paclitaxel versus AC followed by paclitaxel in women with node positive or high risk node negative breast cancer, NCIC CTG MA.21: Results of an interim analysis
Differential proteomic analysis of formalin fixed paraffin embedded breast tissue encompassing a range of pathologic states
Skin sparing mastectomy-how thorough can breast tissue removal be?
Gene expression profiling to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/neu-positive metastatic breast cancer
Akt inhibition enhances troglitazone-mediated anti-proliferative effects
Identification of a novel BRIP1 germline mutation in a woman with early onset breast cancer
The synthetic cannabinoid nabilone improves pain and symptom management in cancer patients
Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence despite postoperative radiotherapy after breast conserving surgery
Oral ibandronate provides significant palliative benefit in metastatic breast cancer patients who have experienced bony progression or a skeletal related event (SRE) despite first-line bisphosphonate therapy
Validation of the prognostic algorithm based on five monoclonal antibody immunohistochemistry test in node negative ER+ breast cancer-NSABP B14 and B20 studies
Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes
Expression of the HER2-associated proteins Tob-1, TGF beta und P4HB in mammary Paget's disease
ERRATUM
ERRATUM